Preclinical studies and absorbed dose estimation of [(89)Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumors. Zolghadri S, Mohammadpour-Ghazi F, Yousefnia H. Appl Radiat Isot 2024;210:111379.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zolghadri S, Mohammadpour-Ghazi F, Yousefnia H. Preclinical studies and absorbed dose estimation of [(89)Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumors. Appl Radiat Isot 2024;210:111379.
PMID: 38815448